225 related articles for article (PubMed ID: 37114835)
1. Epileptic spasms in CDKL5 deficiency disorder: Delayed treatment and poor response to first-line therapies.
Olson HE; Demarest S; Pestana-Knight E; Moosa AN; Zhang X; Pérez-Pérez JR; Weisenberg J; O'Connor Prange E; Marsh ED; Rajaraman RR; Suter B; Katyayan A; Haviland I; Daniels C; Zhang B; Greene C; DeLeo M; Swanson L; Love-Nichols J; Benke T; Harini C; Poduri A
Epilepsia; 2023 Jul; 64(7):1821-1832. PubMed ID: 37114835
[TBL] [Abstract][Full Text] [Related]
2. Response to treatment in a prospective national infantile spasms cohort.
Knupp KG; Coryell J; Nickels KC; Ryan N; Leister E; Loddenkemper T; Grinspan Z; Hartman AL; Kossoff EH; Gaillard WD; Mytinger JR; Joshi S; Shellhaas RA; Sullivan J; Dlugos D; Hamikawa L; Berg AT; Millichap J; Nordli DR; Wirrell E;
Ann Neurol; 2016 Mar; 79(3):475-84. PubMed ID: 26704170
[TBL] [Abstract][Full Text] [Related]
3. Association of Time to Clinical Remission With Sustained Resolution in Children With New-Onset Infantile Spasms.
Yuskaitis CJ; Mytinger JR; Baumer FM; Zhang B; Liu S; Samanta D; Hussain SA; Yozawitz EG; Keator CG; Joshi C; Singh RK; Bhatia S; Bhalla S; Shellhaas R; Harini C;
Neurology; 2022 Nov; 99(22):e2494-e2503. PubMed ID: 36038267
[TBL] [Abstract][Full Text] [Related]
4. Response to second treatment after initial failed treatment in a multicenter prospective infantile spasms cohort.
Knupp KG; Leister E; Coryell J; Nickels KC; Ryan N; Juarez-Colunga E; Gaillard WD; Mytinger JR; Berg AT; Millichap J; Nordli DR; Joshi S; Shellhaas RA; Loddenkemper T; Dlugos D; Wirrell E; Sullivan J; Hartman AL; Kossoff EH; Grinspan ZM; Hamikawa L;
Epilepsia; 2016 Nov; 57(11):1834-1842. PubMed ID: 27615012
[TBL] [Abstract][Full Text] [Related]
5. The impact of hypsarrhythmia on infantile spasms treatment response: Observational cohort study from the National Infantile Spasms Consortium.
Demarest ST; Shellhaas RA; Gaillard WD; Keator C; Nickels KC; Hussain SA; Loddenkemper T; Patel AD; Saneto RP; Wirrell E; Sánchez Fernández I; Chu CJ; Grinspan Z; Wusthoff CJ; Joshi S; Mohamed IS; Stafstrom CE; Stack CV; Yozawitz E; Bluvstein JS; Singh RK; Knupp KG;
Epilepsia; 2017 Dec; 58(12):2098-2103. PubMed ID: 29105055
[TBL] [Abstract][Full Text] [Related]
6. Improving Outcomes in Infantile Spasms: Role of Pharmacotherapy.
Iyer A; Appleton R
Paediatr Drugs; 2016 Oct; 18(5):357-66. PubMed ID: 27541933
[TBL] [Abstract][Full Text] [Related]
7. Temporal trends in the cost and use of first-line treatments for infantile epileptic spasms syndrome.
Sánchez Fernández I; Amengual-Gual M; Barcia Aguilar C; Romeu A; Sheikh T; Torres A; Chao J; Jonas R; Gaínza-Lein M; Harini C; Douglass L
Epilepsia; 2023 Mar; 64(3):630-640. PubMed ID: 36600453
[TBL] [Abstract][Full Text] [Related]
8. Long-term analysis of adrenocorticotropic hormone monotherapy for infantile epileptic spasms syndrome with periventricular leukomalacia.
Matsuura R; Hamano SI; Hirata Y; Takeda R; Takeuchi H; Koichihara R; Kikuchi K; Oka A
Seizure; 2023 Jul; 109():40-44. PubMed ID: 37207538
[TBL] [Abstract][Full Text] [Related]
9. A risk-benefit assessment of treatments for infantile spasms.
Nabbout R
Drug Saf; 2001; 24(11):813-28. PubMed ID: 11665869
[TBL] [Abstract][Full Text] [Related]
10. Compliance With Standard Therapies and Remission Rates After Implementation of an Infantile Spasms Management Guideline.
Mytinger JR; Albert DVF; Twanow JD; Vidaurre J; Tan Y; Brock GN; Ostendorf AP
Pediatr Neurol; 2020 Mar; 104():23-29. PubMed ID: 31911027
[TBL] [Abstract][Full Text] [Related]
11. Very-High-Dose Prednisolone Before ACTH for Treatment of Infantile Spasms: Evaluation of a Standardized Protocol.
Eliyan Y; Heesch J; Alayari A; Rajaraman RR; Sankar R; Hussain SA
Pediatr Neurol; 2019 Oct; 99():16-22. PubMed ID: 31331669
[TBL] [Abstract][Full Text] [Related]
12. Vigabatrin with hormonal treatment versus hormonal treatment alone (ICISS) for infantile spasms: 18-month outcomes of an open-label, randomised controlled trial.
O'Callaghan FJK; Edwards SW; Alber FD; Cortina Borja M; Hancock E; Johnson AL; Kennedy CR; Likeman M; Lux AL; Mackay MT; Mallick AA; Newton RW; Nolan M; Pressler R; Rating D; Schmitt B; Verity CM; Osborne JP;
Lancet Child Adolesc Health; 2018 Oct; 2(10):715-725. PubMed ID: 30236380
[TBL] [Abstract][Full Text] [Related]
13. Practice parameter: medical treatment of infantile spasms: report of the American Academy of Neurology and the Child Neurology Society.
Mackay MT; Weiss SK; Adams-Webber T; Ashwal S; Stephens D; Ballaban-Gill K; Baram TZ; Duchowny M; Hirtz D; Pellock JM; Shields WD; Shinnar S; Wyllie E; Snead OC; ;
Neurology; 2004 May; 62(10):1668-81. PubMed ID: 15159460
[TBL] [Abstract][Full Text] [Related]
14. Prospective preliminary analysis of the development of autism and epilepsy in children with infantile spasms.
Askalan R; Mackay M; Brian J; Otsubo H; McDermott C; Bryson S; Boyd J; Snead C; Roberts W; Weiss S
J Child Neurol; 2003 Mar; 18(3):165-70. PubMed ID: 12731640
[TBL] [Abstract][Full Text] [Related]
15. Clinical profile and treatment of infantile spasms using vigabatrin and ACTH--a developing country perspective.
Ibrahim S; Gulab S; Ishaque S; Saleem T
BMC Pediatr; 2010 Jan; 10():1. PubMed ID: 20078871
[TBL] [Abstract][Full Text] [Related]
16. Epileptic spasms in tuberous sclerosis complex.
Hsieh DT; Jennesson MM; Thiele EA
Epilepsy Res; 2013 Sep; 106(1-2):200-10. PubMed ID: 23796861
[TBL] [Abstract][Full Text] [Related]
17. Treatment modalities for infantile spasms: current considerations and evolving strategies in clinical practice.
Hollenshead PP; Jackson CN; Cross JV; Witten TE; Anwar AI; Ahmadzadeh S; Shekoohi S; Kaye AD
Neurol Sci; 2024 Feb; 45(2):507-514. PubMed ID: 37736852
[TBL] [Abstract][Full Text] [Related]
18. Clinical manifestations and epilepsy treatment in Japanese patients with pathogenic CDKL5 variants.
Kobayashi Y; Tohyama J; Takahashi Y; Goto T; Haginoya K; Inoue T; Kubota M; Fujita H; Honda R; Ito M; Kishimoto K; Nakamura K; Sakai Y; Takanashi JI; Tanaka M; Tanda K; Tominaga K; Yoshioka S; Kato M; Nakashima M; Saitsu H; Matsumoto N
Brain Dev; 2021 Apr; 43(4):505-514. PubMed ID: 33436160
[TBL] [Abstract][Full Text] [Related]
19. Prioritizing Hormone Therapy Over Vigabatrin as the First Treatment for Infantile Spasms: A Quality Improvement Initiative.
Mytinger JR; Parker W; Rust SW; Ahrens SM; Albert DVF; Beatty CW; Chrisman J; Clark DJ; Debs A; Denney D; Karn M; Herbst J; Ostendorf AP; Taylor MC; Twanow JDE; Vidaurre J; Patel AD
Neurology; 2022 Nov; 99(19):e2171-e2180. PubMed ID: 36038276
[TBL] [Abstract][Full Text] [Related]
20. Adrenocorticotropic hormone for the treatment of West Syndrome in children.
Shumiloff NA; Lam WM; Manasco KB
Ann Pharmacother; 2013 May; 47(5):744-54. PubMed ID: 23606552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
